BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19465078)

  • 1. Identification of a novel dual E- and N-cadherin antagonist.
    Devemy E; Blaschuk OW
    Peptides; 2009 Aug; 30(8):1539-47. PubMed ID: 19465078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel N-cadherin antagonist.
    Devemy E; Blaschuk OW
    Peptides; 2008 Nov; 29(11):1853-61. PubMed ID: 18655820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel peptide mimetic small molecules of the HAV motif in N-cadherin inhibit N-cadherin-mediated neurite outgrowth and cell adhesion.
    Burden-Gulley SM; Gates TJ; Craig SE; Lou SF; Oblander SA; Howell S; Gupta M; Brady-Kalnay SM
    Peptides; 2009 Dec; 30(12):2380-7. PubMed ID: 19765627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fusion protein N-cadherin-Fc as an artificial extracellular matrix surface for maintenance of stem cell features.
    Yue XS; Murakami Y; Tamai T; Nagaoka M; Cho CS; Ito Y; Akaike T
    Biomaterials; 2010 Jul; 31(20):5287-96. PubMed ID: 20398934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptidomimetic antagonist of TNF-alpha-mediated cytotoxicity identified from a phage-displayed random peptide library.
    Chirinos-Rojas CL; Steward MW; Partidos CD
    J Immunol; 1998 Nov; 161(10):5621-6. PubMed ID: 9820541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INP, a novel N-cadherin antagonist targeted to the amino acids that flank the HAV motif.
    Williams EJ; Williams G; Gour B; Blaschuk O; Doherty P
    Mol Cell Neurosci; 2000 May; 15(5):456-64. PubMed ID: 10833302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody recognition of peptide sequences from the cell-cell adhesion proteins: N- and E-cadherins.
    Lutz KL; Szabo LA; Thompson DL; Siahaan TJ
    Pept Res; 1996; 9(5):233-9. PubMed ID: 9000249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of N-cadherin-dependent neurite outgrowth by small molecule peptide mimetic agonists of the N-cadherin HAV motif.
    Burden-Gulley SM; Gates TJ; Craig SE; Gupta M; Brady-Kalnay SM
    Peptides; 2010 May; 31(5):842-9. PubMed ID: 20153391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of antibiotic clarithromycin binding peptide displayed by T7 phage particles.
    Morimura T; Noda N; Kato Y; Watanabe T; Saitoh T; Yamazaki T; Takada K; Aoki S; Ohta K; Ohshige M; Sakaguchi K; Sugawara F
    J Antibiot (Tokyo); 2006 Oct; 59(10):625-32. PubMed ID: 17191677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and development of N-cadherin antagonists.
    Blaschuk OW
    Cell Tissue Res; 2012 May; 348(2):309-13. PubMed ID: 22281688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of e-cadherin-mediated homotypic adhesion of Caco-2 cells: a novel evaluation assay for peptide activities in modulating cell-cell adhesion.
    Kobayashi N; Ikesue A; Majumdar S; Siahaan TJ
    J Pharmacol Exp Ther; 2006 Apr; 317(1):309-16. PubMed ID: 16371447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening peptides binding specifically to large intestinal cancer LoVo cells from phage random peptide library].
    Liao KX; Yao XQ; Wu CT; Lin F; Wu WL; Zeng SD; Luo YQ; Lei ST
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):986-90. PubMed ID: 18583245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion.
    Ryniers F; Stove C; Goethals M; Brackenier L; Noë V; Bracke M; Vandekerckhove J; Mareel M; Bruyneel E
    Biol Chem; 2002 Jan; 383(1):159-65. PubMed ID: 11928810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide-based carrier for intracellular delivery of proteins into malignant glial cells in vitro.
    Wu C; Lo SL; Boulaire J; Hong ML; Beh HM; Leung DS; Wang S
    J Control Release; 2008 Sep; 130(2):140-5. PubMed ID: 18632177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cadherin engagement protects human β-cells from apoptosis.
    Parnaud G; Gonelle-Gispert C; Morel P; Giovannoni L; Muller YD; Meier R; Borot S; Berney T; Bosco D
    Endocrinology; 2011 Dec; 152(12):4601-9. PubMed ID: 21990317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An FcgammaRIIa-binding peptide that mimics the interaction between FcgammaRIIa and IgG.
    Cendron AC; Wines BD; Brownlee RT; Ramsland PA; Pietersz GA; Hogarth PM
    Mol Immunol; 2008 Jan; 45(2):307-19. PubMed ID: 17673295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary structure of the HAV peptide which regulates cadherin-cadherin interaction.
    Lutz KL; Jois SD; Siahaan TJ
    J Biomol Struct Dyn; 1995 Dec; 13(3):447-55. PubMed ID: 8825724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Ca2+ affinities and functional implications of the two synaptic adhesion molecules cadherin-11 and N-cadherin.
    Heupel WM; Baumgartner W; Laymann B; Drenckhahn D; Golenhofen N
    Mol Cell Neurosci; 2008 Mar; 37(3):548-58. PubMed ID: 18201900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cadherins as novel targets for anti-cancer therapy.
    Blaschuk OW; Devemy E
    Eur J Pharmacol; 2009 Dec; 625(1-3):195-8. PubMed ID: 19836380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.